Darwin AG: Novogenia supplies a leading healthcare group in the United Arab Emirates (UAE)

Munich, November 10, 2025 (pta030/10.11.2025/14:00 UTC+1)

Novogenia GmbH, a wholly owned subsidiary of Darwin AG, will play a key role in implementing the new 10XREVIV initiative in Abu Dhabi as part of the partnership announced by M42 (UAE), 10X Health (USA), and REVIV Global (UK).

The collaboration focuses on the introduction of an AI-powered Precision Nutrition System that combines genetic data, blood biomarkers, and nutritional science to enable highly personalized health optimization.

Novongenia GmbH will exclusively handle both the genetic analyses and the production of the personalized micronutrient formulations. This further demonstrates the Austrian subsidiary of Darwin AG's expertise in molecular genetic diagnostics and the development of individualized nutritional supplements.

"The construction of this high-end clinic is, for me, the first step towards a modern, data-driven healthcare system for the United Arab Emirates. I very much hope that this partnership will develop into a model that grows beyond Abu Dhabi in the long term – and that we will be able to provide the entire region with such a system in the future" analyzes Dr. Daniel Wallerstorfer, CEO of Darwin AG.

A milestone for precision medicine innovation

Headquartered in Abu Dhabi, M42 is one of the region's leading healthcare and life sciences companies. Formed from the merger of G42 Healthcare and Mubadala Health – two organizations with close ties to the Abu Dhabi government – the company combines cutting-edge genomics, AI, and data platforms.

M42 is driving numerous initiatives with the Department of Health – Abu Dhabi to develop personalized medicine and data-driven healthcare solutions.

Global technology partners like Microsoft are also investing heavily in expanding the UAE's AI infrastructure. With an investment of US$15.2 billion over the coming years, Microsoft is strengthening its partnership with the G42 Group—the strategic environment from which M42 emerged. This momentum underscores Abu Dhabi's growing importance as a global hub for AI-powered healthcare innovation.

Significance for the DARWIN Group

As a European provider of genetic analyses and personalized nutritional supplements, DARWIN AG sees this initiative as an important step toward the international networking of precision and preventive medicine.

The collaboration between M42, 10X Health, and REVIV demonstrates how cutting-edge genetics, biomarker analyses, and AI-powered personalization are merging to create a new standard for health and performance optimization.

"We are delighted about this significant partnership, which sends a strong signal for the future of personalized health. M42, 10X Health, and REVIV combine scientific excellence and visionary thinking – a combination that will shape the next generation of healthcare. For DARWIN AG and our subsidiary Novogenia, it is inspiring to be part of this global movement that focuses on prevention, longevity, and individual optimization" commented CEO and founder Dr. Daniel Wallerstorfer.

With the 10XREVIV project, the Darwin Group is strengthening its existing collaboration with international partners in the field of preventive and nutrigenetics to set new standards for personalized nutrition and longevity.

A detailed press release about the partnership between M42, 10X, and REVIV is available at https://m42.ae/media-resources/news/m42-announces-strategic-partnership-with-10x-health-and-reviv-global-to-launch-10xreviv-in-abu-dhabi/.

About Darwin AG

The 'Darwin Group' (i.e., Darwin AG including its subsidiaries and sub-subsidiaries), headquartered in Munich (Germany), is a European biotechnology company specializing in human genetics. The genetic analyses carried out in its own laboratory are used in the diagnosis, therapy, and prevention of diseases as well as in the production of individually designed nutritional supplements and cosmetics. Darwin also acts as a partner for doctors, therapists, pharmacists, nutritionists, or fitness trainers, and helps to ensure the most optimal treatment or care for the patient or client by analyzing their respective genetic predisposition. In addition, Darwin invests in innovative companies in the fields of biotech, healthcare, and life sciences.

About M42

M42 is a global healthcare and life sciences company headquartered in Abu Dhabi. By combining genomics, artificial intelligence, and data-driven precision medicine, M42 offers innovative platforms and clinical solutions to redefine healthcare.

More information: www.m42.ae

About 10X Health

10X Health is a US-based company that develops personalized health and nutrition strategies based on genetic and biomarker-driven analyses. Its goal is to optimize physical and mental performance through data-driven prevention.

More information: www.10xhealthsystem.com

About REVIV Global

REVIV Global is a global network for IV nutritional therapy and wellness treatments. The company combines scientific diagnostics with personalized infusions and nutritional strategies.

More information: www.revivme.com

(end)

Emitter:	Darwin AG Brienner Straße 7 80333 München Germany
Contact Person:	Daniel Wallerstorfer
Phone:	+49 89 20 500 450
E-Mail:	investor.relations@darwin-biotech.com
Website:	www.darwin-biotech.com
ISIN(s):	DE000A3C35W0 (Share)
Stock Exchange(s):	Free Market in Frankfurt, Munich (m:access)